CAMELOT certified as climate neutral
The certification is part of our strategy to reduce over 50% of CO2 emissions by 2026 and to offset all unavoidable emissions.
Leave a message and our experts will get back to you as soon as possible.
Rethinking medtech value chains
Growing competition, market consolidation, enormous growth, increasing pressure to innovate, and the individual product are the challenges of the 2020s. The individualization of pharmaceuticals, applications, and products leads to a growing number of variants and thus complexity along the entire supply chain. Regulation and the use of different technologies are driving up product development costs. At the same time, the demands on production in terms of efficiency and costs are increasing. Strong market growth and consolidation in the market require liquid funds. We help you recognize the potential in these challenges and design your individual path to new market strength.
CAMELOT supports medical device manufacturers with proven, pragmatic methods and concepts to analyze and optimize their entire value chain. The consultants in our medical device practice have many years of in-depth experience in designing and optimizing value chains in the medtech sector.
Our experts who can best support you will reach out shortly to the phone number you have provided.